Chemoradiation for malignant epithelial tumors

Cancer/Radiotherapie

Volumn 2, Issue 1, 1998, Pages 7-11

  Cox, Jd ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemoradiation; Chemotherapy; Local control; Metastasis; Organ preservation; Radiotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG CYTOTOXICITY; ESOPHAGUS CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0031934883     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(98)89055-0     Document Type: Article

References (31)

1. Al-Sarraf M, LeBlanc M, Giri PGS, Fu K, Cooper J, Vuong T, et al. Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study [Abstract] Proc ASCO. 15:1996;313.
2. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, De Cremoux H, Douillard JY, et al. ASTRO Plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys. 20:1991;1183-1190.
3. Arriagada R, Le Chevalier T, Rekacewicz C, Quoix E, De Cremoux H, Douillard JY, Tarayre M. Cisplatin-based chemotherapy (CT) in patients with locally advanced non-small cell lung cancer (NSCLC): late analysis of a French randomized trial. [Abstract] Proc ASCO. 16:1997;446a.
4. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez Gonzalez D, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 15:1997;2040-2049.
5. Byhardt RW, Scott CB, Ettinger DS, Curran WJ, Doggett RLS, Coughlin C, et al. Concurrent hyperfractionated irradiation and chemotherapy for unresectable non-small cell lung cancer. Results of Radiation Therapy Oncology Group (RTOG) 90-15 Cancer. 75:1995;2337-2344.
6. Cox JD, Yesner R, Mietlowski W, Petrovich Z. Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung. Cancer. 44:1979;94-98.
7. Cox JD, Pajak TF, Asbell S, Russell AH, Pedersen J, Byhardt RW, et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 27:1993;493-498.
8. Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, et al. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the respiratory/digestive tracts: new evidence for accelerated proliferation from RTOG Protocol 83-13. Cancer. 69:1992;2744-2748.
9. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 323:1990;940-945.
10. Dong J-T, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barret JC. KA11, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 268:1995;884-886.
11. Douglas RM, Kaufman DS, Zietman AL, Althausen AF, Heney NM, Shipley WU. Conservative surgery, patient selection, and chemoradiation as organ-reserving treatment for muscle-invading bladder cancer. Sem Oncol. 23:1996;614-620.
12. Eisert DR, Cox JD, Komaki R. Irradiation for bronchial carcinoma: Reasons for failure. I. Analysis as a function of dose-time-fractionation. Cancer. 35:1976;2665-2670.
13. Fisher B. Personal contributions to progress in breast cancer research and treatment. Semin Oncol. 23:1996;414-427.
14. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 14:1996;2527-2539.
15. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 23:1992;457-467.
16. Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated 125 I. Int J Radiat Oncol Biol Phys. 21:1991;537-547.
17. Glick JH, Kim K, Earle J, O'Connell MJ. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL). [abstract] Proc ASCO. 14:1996;391.
18. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 326:1992;1593-1598.
19. Kitadai Y, Ellis LM, Takahashi Y, Bucana CD, Anzai H, Tahara T, Fidler IJ. Multiparametric in situ mRNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinoma. Clin Cancer Res. 1:1995;1095-1102.
20. Lee JS, Scott C, Komaki R, Fossella FV, Dundas GS, McDonald S, et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06. J Clin Oncol. 14:1996;1055-1064.
21. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW, Fuks Z. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys. 21:1991;549-566.
22. Miller TP, Dahlberg S, Cassady JR, Spier C, Grogan TM, Carlin S, et al. Three cycles of CHOP (3) plus radiotherapy (RT) is superior to eight cycles of CHOP (8) alone for localized intermediate and high grade non-Hodgkin's lymphoma (NHL): a Southwest Oncology Group Study. [Abstract] Proc ASCO. 15:1996;411.
23. Perez CA, Bauer M, Edelstein S, Gillepsie BW, Birch R. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys. 12:1986;539-547.
24. Pignon J-P, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 327:1992;1618-1624.
25. Pilepich MV, Krall JM, Al-Sarraf M, John MJ, Doggett RL, Sause WT, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma - a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 45:1995;616-623.
26. Saunders MI. A randomized multicentre trial of CHART vs conventional radiotherapy in non-small cell lung cancer. Lung Cancer. 18:1997;28-29. (Suppl 2).
27. Saunders MI, Bennett MH, Dische S, Anderson PJ. Primary tumor control after radiotherapy for carcinoma of the bronchus. Int J Radiat Oncol Biol Phys. 10:1984;499-501.
28. Sause WT, Scott CB, Taylor SG IV, Johnson D, Livingston R, Komaki R, et al. RTOG 88-08 and ECOG 4588: Preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung cancer. J Natl Cancer Inst. 87:1995;198-205.
29. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, et al. Effects of concomitant cisiplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med. 326:1992;524-530.
30. Suit HD, Miralbell R. Potential impact of improvements in radiation therapy on quality of life and survival. Int J Radiat Oncol Biol Phys. 16:1989;891-895.
31. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 10:1992;890-895.